From time to time, we at Genentech feel it is important to post our views on topical public policy issues or initiatives that affect our business and our industry. We hope that by making our positions public and clear, we can open constructive dialogue about the issues and promote the development of creative and thoughtful solutions. Currently, we have statements about the following issues: follow-on biologics, clinical trial transparency and drug pricing.

Feedback We are always interested in hearing from our website visitors. If you have feedback on the public policy section of our website, please take a moment to complete our .